- Home
- MRDN vs VRCA Comparison
MRDN vs VRCA Comparison
Compare MRDN & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRDN | VRCA |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.7M | 88.0M |
| IPO Year | 2008 | 2018 |
Fundamental Metrics
Financial Performance| Metric | MRDN | VRCA |
|---|---|---|
| Price | $14.28 | $5.02 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | ★ 72.5K | 35.8K |
| Earning Date | 04-28-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $182,863,373.00 | $35,577,000.00 |
| Revenue This Year | $16.30 | N/A |
| Revenue Next Year | $12.32 | $94.44 |
| P/E Ratio | $78.22 | ★ N/A |
| Revenue Growth | 21.01 | ★ 370.22 |
| 52 Week Low | $6.01 | $3.28 |
| 52 Week High | $16.09 | $9.82 |
Technical Indicators
Market Signals| Indicator | MRDN | VRCA |
|---|---|---|
| Relative Strength Index (RSI) | 54.75 | 42.49 |
| Support Level | $12.66 | $4.25 |
| Resistance Level | $15.22 | $6.22 |
| Average True Range (ATR) | 1.46 | 0.45 |
| MACD | 0.11 | -0.01 |
| Stochastic Oscillator | 78.19 | 32.05 |
Price Performance
Historical ComparisonAbout MRDN Meridian Holdings Inc. Common Stock
Meridian Holdings Inc is engaged in the online gaming and betting business, providing sports betting, online casino, and gaming operations across multiple jurisdictions in Europe, Africa, and Central and South America. The company has three reportable segments: MeridianBet Group, GMAG, and RKings & CFAC. The MeridianBet Group segment includes retail and online sports betting, casinos, and related gaming operations. The GMAG segment focuses on the resale of third-party gaming content, mainly serving customers in the Asia-Pacific region. The RKings & CFAC segment is involved in pay-to-enter prize competitions and trade promotions conducted in the United Kingdom and Australia. It generates the majority of its revenue from the MeridianBet Group segment.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.